Literature DB >> 26409647

A delayed chronic pain like condition with decreased Kv channel activity in a rat model of Gulf War Illness pain syndrome.

T J Nutter1, R D Johnson2, B Y Cooper3.   

Abstract

Following their return from deployment, Gulf War (GW) veterans reported widespread joint and muscle pain at rates that far exceeded those of soldiers returning from other conflicts. It is widely believed that exposure to insecticides, repellants and nerve gas prophylactics contributed to the symptoms of Gulf War Illness (GWI), but an animal model of GW pain has been elusive. In our previous work, we observed that 4-8 weeks exposure to pyridostigmine bromide (PB), permethrin and chlorpyrifos could produce persistent alterations in the physiology of Nav1.9 and Kv7 expressed in deep tissue nociceptors of the dorsal root ganglion. However, behavioral assessments from these same rats were not consistent with a delayed pain syndrome similar to that of GWI pain. In the present studies, we intensified the exposure to anticholinesterases PB and chlorpyrifos while retaining the same dosages. Animals receiving the intensified protocol for 30 days exhibited significant increases in resting for about 8 weeks after exposure. Thereafter, all measures were comparable to controls. Animals treated with intensified anticholinesterases for 60 days exhibited increased resting and reduced movement 12 weeks post-exposure. In whole cell patch studies, muscle and vascular nociceptor KDR and Kv7 ion channels exhibited increased amplitude relative to controls (e.g., normalized current and/or peak conductance) at 8 weeks post-exposures; however, at 12 weeks post-exposure, the amplitude of these currents was significantly decreased in muscle nociceptors. In current clamp studies, muscle nociceptors also manifested increased action potential duration, afterhyperpolarization and increased discharge to muscarinic agonists 12 weeks post-exposure. The decline in activity of muscle nociceptor KDR and Kv7 channel proteins was consistent with increased nociceptor excitability and a delayed myalgia in rats exposed to GW chemicals.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; Gulf War Syndrome; Insecticide; K(v)7; Neurotoxicity; Nociceptor

Mesh:

Substances:

Year:  2015        PMID: 26409647     DOI: 10.1016/j.neuro.2015.09.010

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  5 in total

1.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

2.  Discovery and identification of O, O-diethyl O-(4-(5-phenyl-4, 5-dihydroisoxazol-3-yl) phenyl) phosphorothioate (XP-1408) as a novel mode of action of organophosphorus insecticides.

Authors:  Zhigang Zeng; Ying Yan; Bingfeng Wang; Niu Liu; Hanhong Xu
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

3.  A role for neuroimmune signaling in a rat model of Gulf War Illness-related pain.

Authors:  Michael J Lacagnina; Jiahe Li; Sabina Lorca; Kenner C Rice; Kimberly Sullivan; James P O'Callaghan; Peter M Grace
Journal:  Brain Behav Immun       Date:  2020-10-27       Impact factor: 7.217

4.  Pyrethroids inhibit K2P channels and activate sensory neurons: basis of insecticide-induced paraesthesias.

Authors:  Aida Castellanos; Alba Andres; Laura Bernal; Gerard Callejo; Nuria Comes; Arcadi Gual; Jonathan P Giblin; Carolina Roza; Xavier Gasull
Journal:  Pain       Date:  2018-01       Impact factor: 7.926

Review 5.  Acetylcholinesterase inhibitor exposures as an initiating factor in the development of Gulf War Illness, a chronic neuroimmune disorder in deployed veterans.

Authors:  Lindsay T Michalovicz; Kimberly A Kelly; Kimberly Sullivan; James P O'Callaghan
Journal:  Neuropharmacology       Date:  2020-04-02       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.